Berkeley Lights Publicizes CEO Transition and Preliminary Full Yr 2021 Monetary Replace

Firm Gives 2022 Income Progress Outlook

EMERYVILLE, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) — Berkeley Lights, Inc., (Nasdaq: BLI), (“BLI” or “the Firm”), a pacesetter in digital cell biology, at this time introduced that Eric D. Hobbs, Ph.D. will transition from his function as chief government officer (CEO) and member of the board of administrators to president of the Antibody Therapeutics enterprise line. The Firm is initiating a seek for a brand new CEO because it continues to execute on its enterprise technique, together with the profitable addition of providers to its portfolio of product choices. Dr. Hobbs will proceed

Read More Read More